US FDA Approves Lidocaine and Prilocaine Cream of Aleor Dermaceuticals

The company ‘Alembic Pharmaceuticals Limited’ announced that, its wholly owned subsidiary known as Aleor Dermaceuticals Limited has now received a final approval from the Food and Drug Administration (FDA) of the United States for the company’s ANDA (Abbreviated New Drug Application) for the Prilocaine and Lidocaine Cream USP of 2.5 percent/2.5 percent. The US FDA […]

Continue Reading